- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04289493
DUbbing Language-therapy CINEma-based in Aphasia Post-Stroke
November 22, 2021 updated by: Instituto de Investigación Hospital Universitario La Paz
DUbbing Language-therapy CINEma-based in Aphasia Post-Stroke (DULCINEA). A Feasibility Cross-over Pilot-trial
The DULCINEA study aims to develop and validate a new therapy that integrates essential language characteristics and functional communication by dubbing scenes from television series that represent daily situations.
It will be a randomized, crossed over, interventional pilot study recruiting 54 patients with poststroke nonfluent aphasia.
Patients will be treated individually in 40-minute sessions twice a week for 8 weeks.
In each session, a speech therapist and an actor will select the clips with muted words or sentences that have been detected as functionally meaningful for each patient.
Outcomes will be assessed as significant differences in two aphasia tests.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The DULCINEA study aims to develop and validate a new therapy that integrates essential language characteristics and functional communication by dubbing scenes from TV series that represent daily situations.
It will be a randomized, crossed over, interventional pilot study recruiting 54 patients with poststroke nonfluent aphasia from the departments of Neurology and Rehabilitation from La Paz University Hospital and also from the "Afasia Activa" association.
After meeting all inclusion and none of the exclusion criteria and signing informed consent, patients will be randomised (1:1) in two different treatment groups.
The first group will receive therapy within the first 3 months of their inclusion with a subsequent period of another 3 months without therapy (thus, serving as group 2 controls).
Group 2 will initiate therapy after 3 months since their inclusion (serving as group 1 controls during the first 3 months).
Therapy consists of 17 sessions performed in a eight week period (1 baseline session and 16 dubbing sessions), each lasting 40 minutes, in which the patient will be asked to dubb words or sentences previously selected and considered as functionally meaningful for them.
These words will be chosen through an online survey performed by a representative group of aphasic patients and the study patients´own relatives in the baseline treatment session.
Outcomes will be assessed as significant differences in two aphasia tests (CAL questionnaire and the BDAE).
Study Type
Interventional
Enrollment (Anticipated)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Blanca Fuentes Gimeno
- Phone Number: +34 917277444
- Email: blanca.fuentes@salud.madrid.org
Study Contact Backup
- Name: Elena de Celis Ruiz
- Phone Number: +34 917277444
- Email: elena.decelis.ruiz@idipaz.es
Study Locations
-
-
-
Madrid, Spain, 28046
- Recruiting
- La Paz University Hospital
-
Principal Investigator:
- Blanca Fuentes Gimeno
-
Sub-Investigator:
- Silvia Pastor Yvorra
-
Sub-Investigator:
- María Alonso de Leciñana
-
Sub-Investigator:
- Elena de Celis Ruiz
-
Sub-Investigator:
- Raquel Gutiérrez Zúñiga
-
Sub-Investigator:
- Ricardo Riguel Bobillo
-
Sub-Investigator:
- Gerardo Ruiz Ares
-
Sub-Investigator:
- Jorge Rodríguez Pardo
-
Contact:
- Blanca Fuentes Gimeno
- Phone Number: +34 917277444
- Email: blanca.fuentes@salud.madrid.org
-
Contact:
- Elena de Celis Ruiz
- Phone Number: +34 917277444
- Email: elena.decelis.ruiz@idipaz.es
-
Sub-Investigator:
- Lydia de la Fuente Gómez
-
Sub-Investigator:
- Cristian Sempere Iborra
-
Sub-Investigator:
- José López Tàppero
-
Sub-Investigator:
- Marta Martín Alonso
-
Sub-Investigator:
- Paloma Blanco
-
Sub-Investigator:
- Nereida Bueno
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- nonfluent aphasia due to unilateral stroke in the left hemisphere without neuroimaging evidence of lesions in the right hemisphere.
- the patient should have received a standard program of conventional speech therapy after stroke, remaining with aphasia with the following characteristics: severely restricted language, poor repetition (even for single words), not exceeding the 70th percentile in the Boston Diagnostic Aphasia Examination (BDAE) for repetition. Moderately preserved language comprehension: listening comprehension exceeding the 15th percentile of BDAE (average score obtained in three areas: word comprehension, commands and complex ideational material).
- Signed informed consent.
Exclusion Criteria:
- Any clinical condition (short life expectancy, coexisting disease) or other characteristics that precluded appropriate follow-up.
- Participation in any therapeutic trial evaluating poststroke recovery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1: first to receive therapy
27 patients that will receive study specific speech therapy in the first 3 months since study inclusion.
From months 3-6 they will be group 2 controls.
|
17 therapy sessions in which the patients will be asked to dubb words or sentences from television series previously considered functionally meaningful for them.
|
Experimental: Group 2: second to receive therapy
27 patients that will receive study specific speech therapy during months 3-6 since study inclusion.
During the first 3 months of the study period, they will be group 1 controls.
|
17 therapy sessions in which the patients will be asked to dubb words or sentences from television series previously considered functionally meaningful for them.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Communicative Activity Log (CAL) questionnaire
Time Frame: Changes in score at six months
|
Questionnaire that evaluates quantity and quality of aphasic patient communication, with 18 different questions in each item.
Each question belonging to these two items is answered as a 6 point scale, where 0 is the worst and 5 is the best score.
|
Changes in score at six months
|
Boston Diagnostic Aphasia Examination (BDAE)
Time Frame: Changes in score at six months
|
Neuropsycological battery that evaluates language skills based on perceptual modalities (auditory, visual, and gestural), processing functions (comprehension, analysis, problem-solving), and response modalities (writing, articulation, and manipulation).
There are five subtests which include: conversational and expository speech, auditory comprehension, oral expression, reading, and writing.
Its results can be used to classify patient's language profiles into one of the localization based classifications of aphasia, and it also provides a severity rating.
|
Changes in score at six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
General Health Questionnaire (GQH-12)
Time Frame: Changes in score at six months
|
The General Health Questionnaire (GHQ) is a psychometric screening tool to identify common psychiatric conditions.
It comprises 12 questions, each one with a four point scale answer.
|
Changes in score at six months
|
Stroke and aphasia Quality of Life Scale (SAQOL-39)
Time Frame: Changes in score at six months
|
SAQOL-39 is an interview-administered self-report scale that comprises the 49 items of the SS-QOL (modified to be communicatively accessible to people with aphasia) and 4 additional items that measure speech comprehension, difficulties with decision-making and and impact of language problems on family and social life.
Questions are answered with a five point scale.
|
Changes in score at six months
|
Western Aphasia Battery Revised (WAB-R)
Time Frame: Changes in score at six months
|
This neuropsycological test assesses linguistic and non-linguistic skills comprised of 8 subtest (32 short tasks).
It identifies aphasia and classifies the type and severity of aphasia disorders.
|
Changes in score at six months
|
Stroke Aphasic Depression Questionnaire (SADQ10)
Time Frame: Changes in score at six months
|
This is a brief questionnaire with 10 items testing depression symptoms within the last week in aphasic patients.
Each item scores in a four point scale.
|
Changes in score at six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 18, 2020
Primary Completion (Anticipated)
February 1, 2023
Study Completion (Anticipated)
February 1, 2023
Study Registration Dates
First Submitted
February 20, 2020
First Submitted That Met QC Criteria
February 27, 2020
First Posted (Actual)
February 28, 2020
Study Record Updates
Last Update Posted (Actual)
December 3, 2021
Last Update Submitted That Met QC Criteria
November 22, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DULCINEA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aphasia, Post-Ictal
-
Universidad Católica San Antonio de MurciaComplejo Asistencial Hermanas Hospitalarias del Sagrado Corazón de Jesús; Hospital...Recruiting
-
Hospices Civils de LyonCompletedEpilepsy | Ictal/Post-ictal HypoxemiaFrance
-
Icahn School of Medicine at Mount SinaiNeuro Device Group S.A.Recruiting
-
Instituto de Investigación Hospital Universitario...CompletedPost Stroke Aphasia
-
Charite University, Berlin, GermanyGerman Federal Ministry of Education and ResearchUnknownPost-Stroke Chronic Aphasia | Anomia (Word-retrieval Impairment)Germany
-
University Medicine GreifswaldCompletedPost-stroke Depression | Post-stroke AphasiaGermany
-
University of South CarolinaNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Aphasia | Stroke, Ischemic | Aphasia, Broca | Aphasia, Anomic | Aphasia, Global | Aphasia, Fluent | Aphasia, Mixed | Aphasia, Jargon | Aphasia, Expressive | Aphasia, ConductionUnited States
-
Scion NeuroStimDuke UniversityCompletedPost-stroke AphasiaUnited States
-
Universitaire Ziekenhuizen KU LeuvenRecruitingStatus Epilepticus | Positron-emission Tomography | Ictal-interictal Continuum | Perfusion Weighted MRI | Perfusion CTBelgium
-
University of CincinnatiChildren's Hospital Medical Center, CincinnatiUnknownAphasia | Post-stroke AphasiaUnited States
Clinical Trials on Language and functional communication therapy
-
Riphah International UniversityRecruiting
-
Sehat Medical ComplexRecruitingSpeech, Language Developmental Delay From Hearing LossPakistan
-
Riphah International UniversityRecruitingHearing Impaired ChildrenPakistan
-
Rutgers, The State University of New JerseyUtah State UniversityCompletedIncreasing Functional Communicative Behavior | Decreasing Destructive Behavior | Analysis of Treatment Dosage | Empirically Determined Reinforcement Schedule ThinningUnited States
-
University of Kansas Medical CenterNational Center for Advancing Translational Sciences (NCATS)Recruiting
-
University of KentUnknownIntellectual DisabilityUnited Kingdom
-
University of NebraskaTerminatedAggression | Self-Injurious BehaviorUnited States
-
Western Kentucky UniversityNational Institute of General Medical Sciences (NIGMS)TerminatedProblem Behavior | Intellectual Disability | Developmental DisorderUnited States
-
Centre Psychothérapique de NancyRecruitingSchizophrenia | Language Disorders | Psychosis | At-risk Mental StateFrance
-
State University of New York - Upstate Medical...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Completed